Oxbridge Re - OXBR Stock Forecast, Price & News

Oxbridge Re's stock was trading at $5.62 at the beginning of the year. Since then, OXBR shares have decreased by 62.8% and is now trading at $2.09.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Friday, November 11th 2022.
View our OXBR earnings forecast.

Oxbridge Re Holdings Limited (NASDAQ:OXBR) issued its earnings results on Monday, August, 15th. The insurance provider reported $0.01 earnings per share for the quarter. The insurance provider had revenue of $0.50 million for the quarter. Oxbridge Re had a net margin of 83.77% and a trailing twelve-month return on equity of 48.29%.

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxbridge Re investors own include Bionano Genomics (BNGO), OrganiGram (OGI), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI) and Evolve Transition Infrastructure (SNMP).

Oxbridge Re trades on the NASDAQ under the ticker symbol "OXBR."

Shares of OXBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OXBR stock can currently be purchased for approximately $2.09.

Oxbridge Re (NASDAQ:OXBR) has a market capitalization of $12.08 million and generates $10.23 million in revenue each year. The insurance provider earns $8.56 million in net income (profit) each year or $1.35 on an earnings per share basis.

Oxbridge Re's mailing address is SUITE 201 42 EDWARD STREET PO BOX 469, GEORGE TOWN E9, KY1-9006. The official website for the company is www.oxbridgere.com. The insurance provider can be reached via phone at (345) 749-7570.